Unicycive Therapeutics, Inc.(UNCY),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

UNCY Unicycive Therapeutics, Inc.

Trading 11-05 10:15:37 EST

3.51

-0.24

-6.52%

High3.72	Low3.50	Vol173.88K
Open3.69	D1 Closing3.75	Amplitude5.87%
Mkt Cap97.65M	Tradable Cap97.54M	Total Shares27.86M
T/O616.24K	T/O Rate0.62%	Tradable Shares27.82M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"UNCY","market":"US","secType":"STK","nameCN":"Unicycive Therapeutics, Inc.","latestPrice":3.5056,"timestamp":1793891705522,"preClose":3.75,"halted":0,"volume":173881,"delay":0,"changeRate":-0.06517333333333337,"floatShares":27823043,"shares":27855300,"eps":-1.558501,"marketStatus":"Trading","change":-0.2444,"latestTime":"11-05 10:15:37 EST","open":3.69,"high":3.72,"low":3.5,"amount":616239.6716991,"amplitude":0.058667,"askPrice":3.52,"askSize":1000,"bidPrice":3.5,"bidSize":156,"shortable":3,"etf":0,"ttmEps":-1.558501,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1793912400000},"marketStatusCode":2,"adr":0,"listingDate":1623988800000,"exchange":"NASDAQ","adjPreClose":3.75,"preHourTrading":{"tag":"盘前","latestPrice":3.72,"preClose":3.75,"latestTime":"09:27 EST","volume":372,"amount":1363.4921952,"timestamp":1793888879967,"change":-0.03,"changeRate":-0.008,"amplitude":0.114667},"postHourTrading":{"tag":"盘后","latestPrice":3.751,"preClose":3.75,"latestTime":"19:30 EST","volume":4502,"amount":16884.406,"timestamp":1793838602988,"change":0.001,"changeRate":0.000267,"amplitude":0.000267},"volumeRatio":1.249801,"impliedVol":1.7499,"impliedVolPercentile":0.6853},"requestUrl":"/m/hq/s/UNCY/tweets","defaultTab":"tweets","newsList":[{"id":"2680760034","title":"Unicycive Therapeutics Presents OLC Regulatory Update with March 25, 2027 FDA Decision Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2680760034","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680760034?lang=en_us&edition=fundamental","pubTime":"2026-11-03 04:52","pubTimestamp":1793652729,"startTime":"0","endTime":"0","summary":"Unicycive Therapeutics presents OLC regulatory update with March 25, 2027 FDA decision targetUnicycive Therapeutics’ OLC application resubmission is under FDA review, with a March 25, 2027, target dec","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261102:nNDL5jgn7Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","UNCY","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679314752","title":"Unicycive Grants Director Meredith Manning 27,000 Stock Options","url":"https://stock-news.laohu8.com/highlight/detail?id=2679314752","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2679314752?lang=en_us&edition=fundamental","pubTime":"2026-10-30 04:46","pubTimestamp":1793306800,"startTime":"0","endTime":"0","summary":"Unicycive Grants Director Meredith Manning 27,000 Stock OptionsUnicycive Therapeutics granted director Meredith Manning 3,350 restricted stock units on Oct. 28, 2026.Manning also received 27,000 stock","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261029:nNDL7PRFHG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UNCY","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679490177","title":"Unicycive Therapeutics Hits a Manufacturing Roadblock: Lawsuit Alleges OLC Approval Risks Were Downplayed","url":"https://stock-news.laohu8.com/highlight/detail?id=2679490177","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2679490177?lang=en_us&edition=fundamental","pubTime":"2026-10-29 01:16","pubTimestamp":1793207769,"startTime":"0","endTime":"0","summary":"THE LAWSUIT: A class action securities lawsuit was filed against Unicycive Therapeutics, Inc. (UNCY) that seeks to recover losses of Unicycive Ther...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/class-action/unicycive-therapeutics-hits-a-manufacturing-roadblock-lawsuit-alleges-olc-approval-risks-were-downplayed?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/class-action/unicycive-therapeutics-hits-a-manufacturing-roadblock-lawsuit-alleges-olc-approval-risks-were-downplayed?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["UNCY","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677048995","title":"Unicycive Therapeutics: Regulatory Overhang Eases as Oxylanthanum Carbonate Advances; Buy Rating Reiterated with Unchanged $30 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2677048995","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677048995?lang=en_us&edition=fundamental","pubTime":"2026-10-23 03:55","pubTimestamp":1792698927,"startTime":"0","endTime":"0","summary":"Maxim Group analyst Jason McCarthy maintained a Buy rating on Unicycive Therapeutics yesterday and set a price target of $30.00. Jason McCarthy has...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/unicycive-therapeutics-regulatory-overhang-eases-as-oxylanthanum-carbonate-advances-buy-rating-reiterated-with-unchanged-30-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/unicycive-therapeutics-regulatory-overhang-eases-as-oxylanthanum-carbonate-advances-buy-rating-reiterated-with-unchanged-30-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["UNCY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677677112","title":"Unicycive Therapeutics Shares Rise After FDA Accepts Resubmitted NDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2677677112","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677677112?lang=en_us&edition=fundamental","pubTime":"2026-10-21 22:07","pubTimestamp":1792591620,"startTime":"0","endTime":"0","summary":"Unicycive Therapeutics shares rose after the company said the Food and Drug Administration has accepted the resubmission of its New Drug Application for oxylanthanum carbonate.The stock was 5% higher,","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","BK4588","BK4139","BK4539","BK4585","UNCY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677689673","title":"Unicycive Therapeutics - FDA Sets Pdufa Target Action Date of March 25, 2027 for Olc Nda","url":"https://stock-news.laohu8.com/highlight/detail?id=2677689673","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677689673?lang=en_us&edition=fundamental","pubTime":"2026-10-21 19:05","pubTimestamp":1792580700,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261021:nTUA3P2P0F:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["UNCY","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677673683","title":"Unicycive Therapeutics - Resubmission Includes Cmc Data from New Drug Product Manufacturing Vendor","url":"https://stock-news.laohu8.com/highlight/detail?id=2677673683","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677673683?lang=en_us&edition=fundamental","pubTime":"2026-10-21 19:05","pubTimestamp":1792580700,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261021:nTUA3P2P0F:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["UNCY","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677673668","title":"Unicycive: if 3Rd-Party Vendor Facility Complies with Current Good Manufacturing Practice, Co to Seek FDA Alignment on Shorter Approval Timeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2677673668","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677673668?lang=en_us&edition=fundamental","pubTime":"2026-10-21 19:05","pubTimestamp":1792580700,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261021:nTUA3P2P0F:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4539","UNCY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677673502","title":"Unicycive Therapeutics Announces FDA Acceptance of Oxylanthanum Carbonate New Drug Application Resubmission and Pdufa Date of March 25, 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2677673502","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677673502?lang=en_us&edition=fundamental","pubTime":"2026-10-21 19:05","pubTimestamp":1792580700,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261021:nTUA3P2P0F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","UNCY","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672513907","title":"Unicycive Therapeutics Appoints Meredith Manning to Board, Names Her Nominating Committee Chair","url":"https://stock-news.laohu8.com/highlight/detail?id=2672513907","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672513907?lang=en_us&edition=fundamental","pubTime":"2026-10-01 19:05","pubTimestamp":1790852739,"startTime":"0","endTime":"0","summary":"Unicycive Therapeutics appoints Meredith Manning to board, names her nominating committee chairUnicycive Therapeutics appointed Meredith Manning to its board.Manning joined the audit, compensation, no","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nNDL422pkh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU0823416689.USD","BK4585","IE00BN0W2T93.GBP","SG9999014021.USD","IE00BGHQF748.EUR","IE00B64PRP62.GBP","BK4588","IE00B3QW5Z07.USD","LU2210149790.SGD","LU0109394709.USD","LU0314104364.USD","SG9999014039.USD","SG9999014005.SGD","IE00BQXX3D17.EUR","LU2065171311.SGD","IE00BQXX3C00.GBP","LU0154245756.USD","LU0320765992.SGD","LU0154245673.USD","LU2065169927.USD","UNCY","BCDF","IE00BN0W2W23.USD","LU0889565916.HKD","LU2065171402.SGD","BK4539","LU2095319765.USD","IE00BKPKM429.USD","BK4112","SG9999014013.SGD","IE00BQXX3F31.USD","NBIX","IE00BN0W2V16.EUR","LU2210150020.SGD","LU2065170008.USD","NDAQ","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672751806","title":"Unicycive Therapeutics Appoints Meredith Manning to Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2672751806","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672751806?lang=en_us&edition=fundamental","pubTime":"2026-10-01 19:05","pubTimestamp":1790852700,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nTUA36Y3JF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","UNCY","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671245933","title":"Unicycive Therapeutics Price Target Cut to $13.00/Share from $15.00 by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2671245933","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671245933?lang=en_us&edition=fundamental","pubTime":"2026-09-29 23:49","pubTimestamp":1790696940,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/UNCY/analyst-ratings","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UNCY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671437692","title":"Unicycive Therapeutics, Inc. : H.c. Wainwright Cuts Target Price to $13 from $15","url":"https://stock-news.laohu8.com/highlight/detail?id=2671437692","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671437692?lang=en_us&edition=fundamental","pubTime":"2026-09-29 23:26","pubTimestamp":1790695595,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nAZN4TMMN8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","UNCY","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671216406","title":"Unicycive Therapeutics announces resubmission of NDA for OLC","url":"https://stock-news.laohu8.com/highlight/detail?id=2671216406","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671216406?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:15","pubTimestamp":1790680531,"startTime":"0","endTime":"0","summary":"Unicycive Therapeutics (UNCY) announced the resubmission of its New Drug Application, NDA, for oxylanthanum carbonate, OLC, the Company’s investiga...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/unicycive-therapeutics-announces-resubmission-of-nda-for-olc-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/unicycive-therapeutics-announces-resubmission-of-nda-for-olc-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","UNCY","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671421639","title":"Unicycive Resubmits FDA NDA for Oxylanthanum Carbonate Phosphate Binder","url":"https://stock-news.laohu8.com/highlight/detail?id=2671421639","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671421639?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:05","pubTimestamp":1790679917,"startTime":"0","endTime":"0","summary":"Unicycive resubmits FDA NDA for oxylanthanum carbonate phosphate binderUnicycive resubmitted its FDA NDA for oxylanthanum carbonate to treat hyperphosphatemia in CKD patients on dialysis.Filing includ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nNDL2RqzJF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014039.USD","IE00B3QW5Z07.USD","IE00BN0W2T93.GBP","IE00B64PRP62.GBP","IE00BQXX3F31.USD","LU2095319765.USD","SG9999014005.SGD","BK4585","BK4588","SG9999014013.SGD","IE00BQXX3C00.GBP","BK4539","NDAQ","IE00BN0W2W23.USD","LU2210150020.SGD","BK4139","SG9999014021.USD","UNCY","IE00BN0W2V16.EUR","BCDF","IE00BQXX3D17.EUR","LU0314104364.USD","LU2210149790.SGD","IE00BGHQF748.EUR","IE00BKPKM429.USD","BK4112"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671521637","title":"Unicycive Therapeutics - FDA Acceptance of Nda Expected Within 30 Days; New Pdufa Date in 6 Months","url":"https://stock-news.laohu8.com/highlight/detail?id=2671521637","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671521637?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:05","pubTimestamp":1790679900,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nTUA84XFVD:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["UNCY","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671216374","title":"Unicycive Therapeutics - Nda Resubmission Includes Cmc Data from New Manufacturing Vendor","url":"https://stock-news.laohu8.com/highlight/detail?id=2671216374","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671216374?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:05","pubTimestamp":1790679900,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nTUA84XFVD:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["UNCY","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671216370","title":"Unicycive Therapeutics Announces Resubmission of New Drug Application for Oxylanthanum Carbonate","url":"https://stock-news.laohu8.com/highlight/detail?id=2671216370","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671216370?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:05","pubTimestamp":1790679900,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nTUA84XFVD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4539","UNCY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671216306","title":"Unicycive Therapeutics - FDA Inspection of Original Manufacturing Vendor Assigned but not Completed as of Sept 29, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2671216306","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671216306?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:05","pubTimestamp":1790679900,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nTUA84XFVD:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["UNCY","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671505532","title":"Unicycive Therapeutics - Lawsuit Alleges Violations Related to Oxylanthanum Carbonate Phosphate Binder Statements - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2671505532","media":"THOMSON REUTERS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671505532?lang=en_us&edition=fundamental","pubTime":"2026-09-29 04:33","pubTimestamp":1790627597,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nFWN45K0DO:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["UNCY","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.unicycive.com","stockEarnings":[{"period":"1week","weight":-0.0027},{"period":"1month","weight":-0.105},{"period":"3month","weight":-0.2574},{"period":"6month","weight":-0.5277},{"period":"1year","weight":-0.1554},{"period":"ytd","weight":-0.3501}],"compareEarnings":[{"period":"1week","weight":-0.0071},{"period":"1month","weight":-0.0104},{"period":"3month","weight":-0.0023},{"period":"6month","weight":0.0396},{"period":"1year","weight":0.1356},{"period":"ytd","weight":0.1245}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Unicycive Therapeutics, Inc., a biotechnology company, develops treatments for various medical conditions in the United States. Its drug candidates include UNI 494, a pro-drug of Nicorandil that is being developed as a treatment for acute kidney injury; and Renazorb (Oxylanthanum Carbonate), which is being developed for the treatment of hyperphosphatemia in patients with chronic kidney disease. Unicycive Therapeutics, Inc. has license agreements with Shilpa Medicare Ltd; Sphaera Pharma Pte. Ltd.; Syneos Health LLC; Inotiv; Lee's Pharmaceutical (HK) Limited; Celerion; and Lotus International Pte Ltd. The company was incorporated in 2016 and is based in Los Altos, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":-0.078139},{"month":2,"riseRate":0.6,"avgChangeRate":0.088088},{"month":3,"riseRate":0.4,"avgChangeRate":0.59683},{"month":4,"riseRate":0.4,"avgChangeRate":-0.11937},{"month":5,"riseRate":0.4,"avgChangeRate":-0.060546},{"month":6,"riseRate":0,"avgChangeRate":-0.217882},{"month":7,"riseRate":0.2,"avgChangeRate":-0.068802},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.095849},{"month":9,"riseRate":0.5,"avgChangeRate":0.016162},{"month":10,"riseRate":0.666667,"avgChangeRate":0.008578},{"month":11,"riseRate":0.666667,"avgChangeRate":0.051007},{"month":12,"riseRate":0.4,"avgChangeRate":0.09852}],"exchange":"NASDAQ","name":"Unicycive Therapeutics, Inc.","nameEN":"Unicycive Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.52.1","shortVersion":"4.52.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Unicycive Therapeutics, Inc.(UNCY),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Unicycive Therapeutics, Inc.(UNCY) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Unicycive Therapeutics, Inc.,UNCY,Unicycive Therapeutics, Inc.股票,Unicycive Therapeutics, Inc.股票老虎,Unicycive Therapeutics, Inc.股票老虎国际,Unicycive Therapeutics, Inc.行情,Unicycive Therapeutics, Inc.股票行情,Unicycive Therapeutics, Inc.股价,Unicycive Therapeutics, Inc.股市,Unicycive Therapeutics, Inc.股票价格,Unicycive Therapeutics, Inc.股票交易,Unicycive Therapeutics, Inc.股票购买,Unicycive Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Unicycive Therapeutics, Inc.(UNCY),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Unicycive Therapeutics, Inc.(UNCY) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction